Back to search

Article

SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine

2019-12-03

Abstract excerpt

The nucleoside analogue nelarabine, the prodrug of arabinosylguanine (AraG), has been known for decades to be effective against acute lymphoblastic leukaemias of T-cell (T-ALL), but not of B-cell (B-ALL) origin. The mechanisms underlying this lineage-specific drug sensitivity have remained elusive. Data from pharmacogenomics studies and from a panel of ALL cell lines revealed an inverse correlation of SAMHD1 expr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
79202ac2-9210-52cd-b004-18dda4a47cea
DOI
10.1101/863183
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabineDOI 10.1101/863183
Select a neighboring publication to make it the new centre.